The Effect of Telenursing Interventions in Empowering Patients With COPD

The Effect of Empowerment Model-Based Telenursing Interventions in Empowering Patients With COPD

The aim of this study is to evaluate the effect of telenursing interventions based on the empowerment model in empowering patients with COPD.

Study Overview

• Status: Completed
• Conditions: Copd; Self Efficacy; Empowerment; Empowerment, Patient
• Intervention / Treatment: Other: Telenursing Interventions

Detailed Description

Patient empowerment is gaining importance and popularity day by day as it can be sustained through telehealth applications. The importance of using communication technologies in providing health care services has become more evident during the COVID-19 pandemic. When integrated into healthcare, technology-centric services provide continuous and easily accessible health data for patients and help facilitate self-monitoring. With tele-nursing, COPD patients can be strengthened in health literacy by teaching them how to access accurate and reliable resources. Through tele-nursing, online support groups and forums can be created among COPD patients so that patients can share their experiences with each other. In this way, social support is provided to patients who have to remain in social isolation due to their illness.

• Study Type: Interventional
• Enrollment (Actual): 90
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Maltepe
    • Istanbul, Maltepe, Turkey, 34844
      • Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Having a confirmed COPD diagnosis for at least one year
• being literate,
• Having the cognitive and mental competence to answer questions,
• Being able to use a mobile phone,
• Disease symptoms are at a level that does not interfere with communication,
• Being in COPD Stage 2 and Stage 3 according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD: Global Initiative for Chronic Obstructive Lung Disease) criteria (30% ≤ FEV1 <80% (of expected)),

Exclusion Criteria:

• The disease is in the acute exacerbation period,
• Dyspnea is at a level that prevents cooperation,
• Having sensory loss regarding vision, hearing and speech,
• Refusal to sign informed consent forms
• It is the refusal of the research to complete the data collection tools.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Telenursing Interventions Group; Participants in this group will receive five hours of face-to-face empowerment training. After the training, the experimental group will be monitored remotely by the researcher nurse via tele-nursing interventions for 12 weeks. Participants will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. Participants will be asked to measure their oxygen saturation and pulse once a day for 12 weeks and record it on the chart. Participants will also be asked to record their complaints in their symptom diary. Participants will be called by the researcher every two weeks (on Thursdays) and informative and reminding text messages prepared specifically for the disease will be sent to the participants three times a week for 12 weeks. Participants will be able to reach the researchers by phone whenever they need.	Other: Telenursing Interventions; Patient follow-up with phone calls and text messages
No Intervention: No Intervention Group; Participants in this group will be given a pulse oximeter, symptom diary, action plan, oxygen saturation-pulse monitoring chart. No intervention will be taken.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
COPD Empowerment Scale	A 31-item scale that evaluates the impact of interventions on individuals with COPD.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Lung Function Test	A spirometri test that evaluates lung capacity. FEV1 values will increase after the intervention.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)
COPD Assesment Test	It is an eight-item test that measures the effects of COPD and deterioration in health status. CAT assessment test score; 0-10 is low 11-20 is considered medium effective, 21-30 is considered highly effective, and 31-40 is considered very high effective.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)
Number of hospital admissions due to COPD exacerbation	The number of hospital admissions due to COPD exacerbation in the experimental group will decrease.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)
Number of hospitalizations due to COPD exacerbation	The number of hospitalizations due to COPD exacerbation in the experimental group will decrease.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)
Modified Barthel Index	A scale that evaluates physical competence and independence in daily living activities. It evaluates 0-15 points with 10 items. On this scale, where the possible score varies between 0 and 100, the higher the score, the more independent the patient is from other people.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)
Modified Medical Research Council	A brief 5-item scale describing dyspnea. Scores between 0 and 1 are considered mild, and scores of 2 and above are considered moderate to severe dyspnea.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)
Inhaler Device Use Skill Scale	An observational test that measures inhaler device usage skill, with 10 usage steps explained. 1 point for correct use of each item; Incomplete or incorrect use is given 0 points.	Pre-test, Post-test (3rd month), Follow-up Test (6th month)

Collaborators and Investigators

• Sponsor: Zahide Aksoy
• Collaborators: The Scientific and Technological Research Council of Turkey
• Investigators: Principal Investigator: Zahide Aksoy, MSc, Marmara University; Study Director: Saime Erol, Ph.D, Marmara University; Study Director: Özlem Oruç, M.D, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital

Study record dates

Study Major Dates

• Study Start (Actual): June 25, 2024
• Primary Completion (Actual): August 25, 2024
• Study Completion (Actual): November 25, 2024

Study Registration Dates

• First Submitted: January 7, 2024
• First Submitted That Met QC Criteria: January 18, 2024
• First Posted (Actual): January 22, 2024

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: March 9, 2025
• Last Verified: March 1, 2025

More Information

Terms related to this study

• Keywords: empowerment; Pulmonary Disease, Chronic Obstructive; telenursing
• Other Study ID Numbers: MarmaraU-HEM-ZA-01

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No